Since MAIT cells are well suited for controlling infection at the pulmonary mucosal surface, fine-tuning of MAIT cell behavior using a suitable vehicle to deliver MR1 ligands to this compartment may constitute a valuable strategy for developing MAIT cell-based vaccines (55, 81, 82). The gene discussed is MR1; the disease is infection.